期刊文献+

代谢综合征相关肾损害 被引量:9

原文传递
导出
摘要 1998年世界卫生组织正式对代谢综合征(metabdic syndrome,MS)命名,现已知它主要由内脏性肥胖、胰岛素的抵抗、糖代谢紊乱、脂代谢异常及高血压组成,并可出现血管内皮功能损害、微炎症、高血凝状态及高尿酸血症等。一般认为,MS系由内脏性肥胖启动,而以胰岛素抵抗为中心,即内脏性肥胖导致胰岛素抵抗,而胰岛素抵抗又导致MS各组分异常。
作者 谌贻璞
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第30期2093-2094,共2页 National Medical Journal of China
  • 相关文献

参考文献19

  • 1Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.Diabet Med,1998,15:539-553.
  • 2World Health Organization.Definition,diagnosis and classification of diabetes mellitus and its complications:report of a WHO Consultation.Part 1:diagnosis and classification of diabetes mellitus.WHO/NCD/NCS,1999,31-32.
  • 3Grundy SM,Brewer Jr HB,Cleeman JI,et al.Definition of metabolic syndrome.Report of the National Heart,Lung,and Blood Institute/American Heart Association conference on scientific issues related to definition.Circulation,2004,109:433-438.
  • 4Alberti KG,Zimmet P,Shaw J.IDF Epidemiology Task Force Consensus Group.The metabolic syndrome-a new worldwide definition.Lancet,2005,366:1059-1062.
  • 5Chen J,Muntner P,Hamm LL,et al.Insulin resistance and risk of chronic kidney disease in nondiabetic US adults.J Am Soc Nephrol,2003,14:469-477.
  • 6Chen J,Muntner P,Hamm LL,et al.The metabolic syndrome and chronic kidney disease in US adults.Ann Intern Med,2004,140:167-174.
  • 7Tuttle KR.Renal manifestations of the metabolic syndrome.Nephrol Dial Transplant,2005,20:861-864.
  • 8中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10. 被引量:3310
  • 9董葆,陈文,程虹,李安,谌贻璞,邹万忠.肥胖相关性局灶节段性肾小球硬化症临床与病理表现[J].中华肾脏病杂志,2002,18(6):389-392. 被引量:32
  • 10Adelman RD.Obesity and renal disease.Curr Opin Nephrol Hypertens,2002,11:331-335

二级参考文献17

  • 1张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 2曹家琪 连志浩 等.队列(群组)研究.流行病学,第2版,第1卷[M].北京:人民卫生出版社,1995.190-206.
  • 3Weisinger JR, Kempson RL, Eldridge FL, et al. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med,1974,81: 440-447.
  • 4Praga M, Hernandez E, Morales E, et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant, 2001, 16:1790-1798.
  • 5Kambham N, Markowitz GS, Valeri AM, et al. Obesity-related glomerulopathy: An emerging epidemic. Kidney Int, 2001, 59:1498 - 1509.
  • 6Adelman R. Obesity and renal disease. Curr Opin Nephrol Hyperten, 2002, 11: 331-335.
  • 7Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbmninemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis,1991, 17: 330.
  • 8Praga M, Morales E, Herrero JC, et al. Absence of hypoalbuminemaia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltrafion. Am J Kidney Dis, 1999, 33: 52-58.
  • 9Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol, 2000,F817-F822.
  • 10Anderson PW, Zhang XY, Tiaa J, et al. Insulin and angiotensin Ⅱ are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int, 1996, 50: 745-753.

共引文献3338

同被引文献61

引证文献9

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部